aod9604 amino acid sequence exact AOD-9604 (acetate) | C78H123N23O23S2 | CID 168310522 AOD-9604 Research Peptide AOD9604 | HLabs

intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 Centers for Disease Control and Prevention

Increased energy may also promote greater physical activity, which can be an important part of your overall wellness and weight management journey

Available option: 5mg / 10mg

While clinical development for obesity was discontinued in 2007 after a Phase IIb trial failed to achieve its primary endpoint, the peptide remains a valuable research tool for investigating adipose tissue biology, lipolytic pathways, and receptor-independent signaling mechanisms

This way your medical needs stay as private as possible